Evidence that the beta-catenin nuclear translocation assay allows for measuring presenilin 1 dysfunction.

G. Van Gassen, C. De Jonghe, M. Nishimura, G. Yu, S. Kuhn, P. St George-Hyslop, C. Van Broeckhoven

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

BACKGROUND: Mutations in the presenilin (PSEN) genes are responsible for the majority of early-onset Alzheimer disease (AD) cases. PSEN1 is a component of a high molecular weight, endoplasmic reticulum, membrane-bound protein complex, including beta-catenin. Pathogenic PSEN1 mutations were demonstrated to have an effect on beta-catenin and glycogen synthase kinase-3beta(GSK-3beta), two members of the wingless Wnt pathway. The nuclear translocation and the stability of beta-catenin, and the interaction between GSK3beta and PSEN1 were influenced. MATERIALS AND METHODS: Stably transfected human embryonic kidney (HEK) 293 cells overexpressing wild-type (wt) and mutant (mt) PSEN1, treated with and without LiCl, were used to isolate cytoplasmic and nuclear fractions. By Western blot analysis, endogenous beta-catenin levels were examined. By analyzing cytosolic fractions of PSEN1, transfected and nontransfected HEK 293 cells, and total brain extracts of AD patients and controls, we evaluated the effect of PSEN1 overexpression on beta-catenin stability. Finally, we analyzed the effect of pathogenic PSEN1 mutations on the interaction between PSEN1 and GSK3beta by co-immunoprecipitation experiments. RESULTS: We report reduced nuclear translocation of beta-catenin in cells stably expressing I143T, G384A, and T113-114ins PSEN1. The G384A PSEN1 mutation showed a similar pronounced effect on nuclear translocation of beta-catenin, as reported for processing of amyloid precursor protein (APP) into amyloid beta(Abeta). Overexpression of PSEN1 and the presence of pathogenic mutations in PSEN1 had no significant effect on the stability of beta-catenin. Nonspecific binding of overexpressed PSEN1 to endogenous GSK3beta was observed when GSK3beta was immunoprecipitated. Immunoprecipitation of PSEN1 in cells overexpressing PSEN1 and in native cells, however, did not result in co-immunoprecipitation of endogenous GSK3beta. CONCLUSION: Our results further establish the nuclear translocation assay of beta-catenin as an adequate alternative for traditional Abeta measurement to evaluate the effect of PSEN1 mutations on biochemical processes. We detected no significant effect of overexpressed wt or mt PSEN1 on the stability of beta-catenin. Finally, co-immunoprecipitation between PSEN1 and GSK3beta was not observed in our experimental setup.

Original languageEnglish (US)
Pages (from-to)570-580
Number of pages11
JournalMolecular medicine (Cambridge, Mass.)
Volume6
Issue number7
StatePublished - Jul 2000

Fingerprint

Presenilin-1
beta Catenin
Immunoprecipitation
Mutation
Amyloid
Alzheimer Disease
Biochemical Phenomena
Presenilins
Kidney
Glycogen Synthase Kinases
Wnt Signaling Pathway
Amyloid beta-Protein Precursor
Endoplasmic Reticulum
Glycogen Synthase Kinase 3 beta
Membrane Proteins
Molecular Weight
Western Blotting

ASJC Scopus subject areas

  • Genetics

Cite this

Van Gassen, G., De Jonghe, C., Nishimura, M., Yu, G., Kuhn, S., St George-Hyslop, P., & Van Broeckhoven, C. (2000). Evidence that the beta-catenin nuclear translocation assay allows for measuring presenilin 1 dysfunction. Molecular medicine (Cambridge, Mass.), 6(7), 570-580.

Evidence that the beta-catenin nuclear translocation assay allows for measuring presenilin 1 dysfunction. / Van Gassen, G.; De Jonghe, C.; Nishimura, M.; Yu, G.; Kuhn, S.; St George-Hyslop, P.; Van Broeckhoven, C.

In: Molecular medicine (Cambridge, Mass.), Vol. 6, No. 7, 07.2000, p. 570-580.

Research output: Contribution to journalArticle

Van Gassen, G, De Jonghe, C, Nishimura, M, Yu, G, Kuhn, S, St George-Hyslop, P & Van Broeckhoven, C 2000, 'Evidence that the beta-catenin nuclear translocation assay allows for measuring presenilin 1 dysfunction.', Molecular medicine (Cambridge, Mass.), vol. 6, no. 7, pp. 570-580.
Van Gassen G, De Jonghe C, Nishimura M, Yu G, Kuhn S, St George-Hyslop P et al. Evidence that the beta-catenin nuclear translocation assay allows for measuring presenilin 1 dysfunction. Molecular medicine (Cambridge, Mass.). 2000 Jul;6(7):570-580.
Van Gassen, G. ; De Jonghe, C. ; Nishimura, M. ; Yu, G. ; Kuhn, S. ; St George-Hyslop, P. ; Van Broeckhoven, C. / Evidence that the beta-catenin nuclear translocation assay allows for measuring presenilin 1 dysfunction. In: Molecular medicine (Cambridge, Mass.). 2000 ; Vol. 6, No. 7. pp. 570-580.
@article{bff4820791ad4970a4caa4fa43373fd5,
title = "Evidence that the beta-catenin nuclear translocation assay allows for measuring presenilin 1 dysfunction.",
abstract = "BACKGROUND: Mutations in the presenilin (PSEN) genes are responsible for the majority of early-onset Alzheimer disease (AD) cases. PSEN1 is a component of a high molecular weight, endoplasmic reticulum, membrane-bound protein complex, including beta-catenin. Pathogenic PSEN1 mutations were demonstrated to have an effect on beta-catenin and glycogen synthase kinase-3beta(GSK-3beta), two members of the wingless Wnt pathway. The nuclear translocation and the stability of beta-catenin, and the interaction between GSK3beta and PSEN1 were influenced. MATERIALS AND METHODS: Stably transfected human embryonic kidney (HEK) 293 cells overexpressing wild-type (wt) and mutant (mt) PSEN1, treated with and without LiCl, were used to isolate cytoplasmic and nuclear fractions. By Western blot analysis, endogenous beta-catenin levels were examined. By analyzing cytosolic fractions of PSEN1, transfected and nontransfected HEK 293 cells, and total brain extracts of AD patients and controls, we evaluated the effect of PSEN1 overexpression on beta-catenin stability. Finally, we analyzed the effect of pathogenic PSEN1 mutations on the interaction between PSEN1 and GSK3beta by co-immunoprecipitation experiments. RESULTS: We report reduced nuclear translocation of beta-catenin in cells stably expressing I143T, G384A, and T113-114ins PSEN1. The G384A PSEN1 mutation showed a similar pronounced effect on nuclear translocation of beta-catenin, as reported for processing of amyloid precursor protein (APP) into amyloid beta(Abeta). Overexpression of PSEN1 and the presence of pathogenic mutations in PSEN1 had no significant effect on the stability of beta-catenin. Nonspecific binding of overexpressed PSEN1 to endogenous GSK3beta was observed when GSK3beta was immunoprecipitated. Immunoprecipitation of PSEN1 in cells overexpressing PSEN1 and in native cells, however, did not result in co-immunoprecipitation of endogenous GSK3beta. CONCLUSION: Our results further establish the nuclear translocation assay of beta-catenin as an adequate alternative for traditional Abeta measurement to evaluate the effect of PSEN1 mutations on biochemical processes. We detected no significant effect of overexpressed wt or mt PSEN1 on the stability of beta-catenin. Finally, co-immunoprecipitation between PSEN1 and GSK3beta was not observed in our experimental setup.",
author = "{Van Gassen}, G. and {De Jonghe}, C. and M. Nishimura and G. Yu and S. Kuhn and {St George-Hyslop}, P. and {Van Broeckhoven}, C.",
year = "2000",
month = "7",
language = "English (US)",
volume = "6",
pages = "570--580",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "Feinstein Institute for Medical Research",
number = "7",

}

TY - JOUR

T1 - Evidence that the beta-catenin nuclear translocation assay allows for measuring presenilin 1 dysfunction.

AU - Van Gassen, G.

AU - De Jonghe, C.

AU - Nishimura, M.

AU - Yu, G.

AU - Kuhn, S.

AU - St George-Hyslop, P.

AU - Van Broeckhoven, C.

PY - 2000/7

Y1 - 2000/7

N2 - BACKGROUND: Mutations in the presenilin (PSEN) genes are responsible for the majority of early-onset Alzheimer disease (AD) cases. PSEN1 is a component of a high molecular weight, endoplasmic reticulum, membrane-bound protein complex, including beta-catenin. Pathogenic PSEN1 mutations were demonstrated to have an effect on beta-catenin and glycogen synthase kinase-3beta(GSK-3beta), two members of the wingless Wnt pathway. The nuclear translocation and the stability of beta-catenin, and the interaction between GSK3beta and PSEN1 were influenced. MATERIALS AND METHODS: Stably transfected human embryonic kidney (HEK) 293 cells overexpressing wild-type (wt) and mutant (mt) PSEN1, treated with and without LiCl, were used to isolate cytoplasmic and nuclear fractions. By Western blot analysis, endogenous beta-catenin levels were examined. By analyzing cytosolic fractions of PSEN1, transfected and nontransfected HEK 293 cells, and total brain extracts of AD patients and controls, we evaluated the effect of PSEN1 overexpression on beta-catenin stability. Finally, we analyzed the effect of pathogenic PSEN1 mutations on the interaction between PSEN1 and GSK3beta by co-immunoprecipitation experiments. RESULTS: We report reduced nuclear translocation of beta-catenin in cells stably expressing I143T, G384A, and T113-114ins PSEN1. The G384A PSEN1 mutation showed a similar pronounced effect on nuclear translocation of beta-catenin, as reported for processing of amyloid precursor protein (APP) into amyloid beta(Abeta). Overexpression of PSEN1 and the presence of pathogenic mutations in PSEN1 had no significant effect on the stability of beta-catenin. Nonspecific binding of overexpressed PSEN1 to endogenous GSK3beta was observed when GSK3beta was immunoprecipitated. Immunoprecipitation of PSEN1 in cells overexpressing PSEN1 and in native cells, however, did not result in co-immunoprecipitation of endogenous GSK3beta. CONCLUSION: Our results further establish the nuclear translocation assay of beta-catenin as an adequate alternative for traditional Abeta measurement to evaluate the effect of PSEN1 mutations on biochemical processes. We detected no significant effect of overexpressed wt or mt PSEN1 on the stability of beta-catenin. Finally, co-immunoprecipitation between PSEN1 and GSK3beta was not observed in our experimental setup.

AB - BACKGROUND: Mutations in the presenilin (PSEN) genes are responsible for the majority of early-onset Alzheimer disease (AD) cases. PSEN1 is a component of a high molecular weight, endoplasmic reticulum, membrane-bound protein complex, including beta-catenin. Pathogenic PSEN1 mutations were demonstrated to have an effect on beta-catenin and glycogen synthase kinase-3beta(GSK-3beta), two members of the wingless Wnt pathway. The nuclear translocation and the stability of beta-catenin, and the interaction between GSK3beta and PSEN1 were influenced. MATERIALS AND METHODS: Stably transfected human embryonic kidney (HEK) 293 cells overexpressing wild-type (wt) and mutant (mt) PSEN1, treated with and without LiCl, were used to isolate cytoplasmic and nuclear fractions. By Western blot analysis, endogenous beta-catenin levels were examined. By analyzing cytosolic fractions of PSEN1, transfected and nontransfected HEK 293 cells, and total brain extracts of AD patients and controls, we evaluated the effect of PSEN1 overexpression on beta-catenin stability. Finally, we analyzed the effect of pathogenic PSEN1 mutations on the interaction between PSEN1 and GSK3beta by co-immunoprecipitation experiments. RESULTS: We report reduced nuclear translocation of beta-catenin in cells stably expressing I143T, G384A, and T113-114ins PSEN1. The G384A PSEN1 mutation showed a similar pronounced effect on nuclear translocation of beta-catenin, as reported for processing of amyloid precursor protein (APP) into amyloid beta(Abeta). Overexpression of PSEN1 and the presence of pathogenic mutations in PSEN1 had no significant effect on the stability of beta-catenin. Nonspecific binding of overexpressed PSEN1 to endogenous GSK3beta was observed when GSK3beta was immunoprecipitated. Immunoprecipitation of PSEN1 in cells overexpressing PSEN1 and in native cells, however, did not result in co-immunoprecipitation of endogenous GSK3beta. CONCLUSION: Our results further establish the nuclear translocation assay of beta-catenin as an adequate alternative for traditional Abeta measurement to evaluate the effect of PSEN1 mutations on biochemical processes. We detected no significant effect of overexpressed wt or mt PSEN1 on the stability of beta-catenin. Finally, co-immunoprecipitation between PSEN1 and GSK3beta was not observed in our experimental setup.

UR - http://www.scopus.com/inward/record.url?scp=0034218323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034218323&partnerID=8YFLogxK

M3 - Article

C2 - 10997338

AN - SCOPUS:0034218323

VL - 6

SP - 570

EP - 580

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

IS - 7

ER -